Close Asset Management Ltd - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 77 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
Close Asset Management Ltd ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$30
-26.8%
11,4000.0%0.00%0.0%
Q2 2023$41
+115.8%
11,400
+28.1%
0.00%
+100.0%
Q1 2023$19
-51.3%
8,900
+178.1%
0.00%
-50.0%
Q4 2022$39
-99.8%
3,2000.0%0.00%
+100.0%
Q3 2022$21,000
+110.0%
3,200
+52.4%
0.00%
Q2 2022$10,000
-66.7%
2,1000.0%0.00%
-100.0%
Q1 2022$30,0000.0%2,1000.0%0.00%0.0%
Q4 2021$30,000
-57.1%
2,100
-33.8%
0.00%
-66.7%
Q3 2021$70,000
+112.1%
3,170
+26.8%
0.00%
+50.0%
Q2 2021$33,000
-56.6%
2,500
-66.7%
0.00%
-50.0%
Q1 2021$76,000
+137.5%
7,5000.0%0.00%
+100.0%
Q4 2020$32,000
+60.0%
7,5000.0%0.00%
+100.0%
Q3 2020$20,000
-23.1%
7,5000.0%0.00%
-50.0%
Q2 2020$26,000
+13.0%
7,5000.0%0.00%0.0%
Q1 2020$23,000
-41.0%
7,5000.0%0.00%
-33.3%
Q4 2019$39,000
+62.5%
7,5000.0%0.00%
+50.0%
Q3 2019$24,000
-11.1%
7,5000.0%0.00%0.0%
Q2 2019$27,0000.0%7,5000.0%0.00%0.0%
Q1 2019$27,000
-47.1%
7,500
+3650.0%
0.00%
-66.7%
Q4 2018$51,000
+410.0%
200
-90.0%
0.01%
+500.0%
Q3 2018$10,000
+100.0%
2,000
+166.7%
0.00%
Q2 2018$5,0000.0%7500.0%0.00%
Q1 2018$5,000
-28.6%
7500.0%0.00%
-100.0%
Q4 2017$7,000
-50.0%
750
-50.0%
0.00%0.0%
Q3 2017$14,000
+16.7%
1,5000.0%0.00%0.0%
Q2 2017$12,000
+20.0%
1,5000.0%0.00%0.0%
Q1 2017$10,0000.0%1,5000.0%0.00%0.0%
Q4 2016$10,0001,5000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 576,317$1,504,0001.50%
Phoenix Holdings Ltd. 197,763$483,0000.02%
Frontier Wealth Management LLC 71,900$188,0000.02%
GSA CAPITAL PARTNERS LLP 19,659$51,0000.01%
Rossmore Private Capital 15,061$39,0000.01%
ETF MANAGERS GROUP, LLC 98,486$255,0000.01%
Virtu Financial LLC 10,450$27,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$15,0000.01%
Sterling Investment Advisors, Ltd. 3,150$8,0000.00%
Qube Research & Technologies Ltd 75,395$197,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders